Acta Neurologica Scandinavica

Aims & Scope

Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience.

The journal's scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area.

Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders.

Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders.

Priority will be given to review of topical subjects.

Papers requiring rapid publication because of their significance and timeliness will be included as 'Clinical commentaries' not exceeding two printed pages, as will 'Clinical commentaries' of sufficient general interest.

Debate within the speciality is encouraged in the form of 'Letters to the editor'.

All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.7
2024	2.90

Journal Rank

Year	Value
2024	5282

Journal Citation Indicator

Year	Value
2024	1182

SJR (SCImago Journal Rank)

Year	Value
2024	0.947

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Irreversible motor impairment in young addicts ? ephedrone, manganism or both?

  Citation: 647

  Authors: K., P., S., J., D., G., T., S.-M.

• Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model

  Citation: 598

  Authors: Maj-Lis, George, Nils, Ingmar, Tadeusz, Bo K.

• Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence

  Citation: 523

  Authors: S., G., B.

• Evolution of the neuropathology of Alzheimer's disease

  Citation: 502

  Authors: H., E.

• The psychiatric comorbidity of epilepsy

  Citation: 449

  Authors: A., M. R., J. W.

• Acute encephalopathy associated with influenza and other viral infections

  Citation: 392

  Authors: M., H., T., M.

• Benzodiazepines in epilepsy: pharmacology and pharmacokinetics

  Citation: 392

  Authors: J., J., J., S.

• Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

  Citation: 355

  Authors: B.

• Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands

  Citation: 341

  Authors: L., M., B., E. M., R., P.

• Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?

  Citation: 333

  Authors: J., P., L., E., H., J.

---